CLINICAL TRIAL: MAINTENANCE STUDY OF IDURONATE-2-SULFATASE REPLACEMENT THERAPY I

临床试验：艾杜糖酸-2-硫酸酯酶替代疗法 I 的维持研究

• 批准号: 7716755
• 负责人: JOSEPH J. MUENZER
• 金额: $ 0.02万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-02 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716755
• 关键词: Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Effectiveness; Enzymes; Funding; Grant; Institution; Maintenance; Mucopolysaccharidosis II; Purpose; Replacement Therapy; Research; Research Personnel; Resources; Safety; Source; Testing; United States National Institutes of Health; iduronate-2-sulfatase; research study

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to continue to test the safety and effectiveness of the experimental enzyme, iduronate-2-sulfatase (I2S) replacement treatment for mucopolysaccharidosis II (MPS II), which is also called Hunter syndrome.

这个子项目是众多研究子项目之一